Department of Oral and Maxillofacial Surgery, Aalborg University Hospital, 18-22 Hobrovej, 9000, Aalborg, Denmark.
Department of Clinical Medicine, The Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Int J Implant Dent. 2021 Oct 1;7(1):99. doi: 10.1186/s40729-021-00379-y.
Autogenous bone graft is considered as the preferred grafting material for maxillary sinus floor augmentation (MSFA). However, harvesting of extraoral or intraoral autogenous bone graft is associated with risk of donor site morbidity and supplementary surgery. From a clinical and patient perspective, it would therefore be an advantage, if postoperative discomfort could be minimized by diminishing the need for autogenous bone graft harvesting. The objective of the present study was to test the hypothesis of no difference in patient's perception of recovery after MSFA with autogenous bone graft from the zygomatic buttress (control) compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral (DPBM) (Test I) or biphasic bone graft material (BBGM) (Test II). Sixty healthy patients were randomly allocated to either control or test groups. Oral Health-related Quality of Life (OHRQoL) was evaluated by Oral Health Impact Profile-14 (OHIP-14) at enrollment. Recovery was estimated by self-administrated questionnaires and visual analog scale assessing pain, social and working isolation, physical appearance, eating and speaking ability, diet variations, sleep impairment and discomfort after 1 week and 1 month. Descriptive statistics was expressed as mean with standard deviation (SD). Correlation between OHRQoL at enrollment and recovery were assessed by linear regression. p-value below 0.05 was considered significant.
Treatment satisfaction and willingness to undergo similar surgery were high in all groups. Average numbers of days with pain and sick leave were 3.5 (SD 3.9) and 0.5 (SD 1.2), respectively, with no significant difference between groups. Moreover, no significant difference in eating and speaking ability, physical appearance, work performance and sleep impairment were seen between groups. Mean OHIP-14 score at enrollment was 9.30 (SD 9.25) (control), 9.95 (SD 7.96) (Test I) and 8.15 (SD 9.37) (Test II), with no significant differences between groups. Impaired OHRQoL, gender or age seems not to predispose for delayed recovery or increased postoperative discomfort.
MSFA with diminutive autogenous bone graft harvesting is associated with high patient satisfaction, limited postoperative discomfort and willingness to undergo similar surgery. Presurgical OHRQoL, gender or age seems not to be associated with impaired patient's perception of recovery.
自体骨移植被认为是上颌窦底提升(MSFA)首选的植骨材料。然而,取自口腔外或口腔内的自体骨移植会增加供区发病率并需要额外手术。从临床和患者的角度来看,如果可以通过减少自体骨移植的需求来最大限度地减少术后不适,这将是一个优势。本研究的目的是验证以下假设:与取自颧骨支柱的自体骨移植(对照组)相比,MSFA 中使用 1:1 混合的自体骨移植和脱蛋白猪骨矿物质(DPBM)(试验 I)或双相骨移植材料(BBGM)(试验 II)后,患者对恢复的感知无差异。将 60 名健康患者随机分配至对照组或试验组。在入组时使用 Oral Health Impact Profile-14(OHIP-14)评估口腔健康相关生活质量(OHRQoL)。通过自我管理问卷和视觉模拟量表评估疼痛、社交和工作孤立、外表、进食和说话能力、饮食变化、睡眠障碍以及术后 1 周和 1 个月时的不适程度来评估恢复情况。描述性统计数据表示为平均值和标准差(SD)。通过线性回归评估入组时 OHRQoL 与恢复之间的相关性。p 值<0.05 被认为具有统计学意义。
所有组的治疗满意度和再次接受类似手术的意愿均较高。平均疼痛天数和病假天数分别为 3.5(SD 3.9)和 0.5(SD 1.2),组间无显著差异。此外,在进食和说话能力、外表、工作表现和睡眠障碍方面,组间无显著差异。入组时的平均 OHIP-14 评分为 9.30(SD 9.25)(对照组)、9.95(SD 7.96)(试验 I)和 8.15(SD 9.37)(试验 II),组间无显著差异。受损的 OHRQoL、性别或年龄似乎不会导致恢复延迟或增加术后不适。
MSFA 中采用少量自体骨移植可获得较高的患者满意度、有限的术后不适和再次接受类似手术的意愿。术前 OHRQoL、性别或年龄似乎与患者对恢复的感知受损无关。